ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 308 filers reported holding ACADIA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.65 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,601,792 | +2215.3% | 268,800 | +1990.9% | 0.13% | +2580.0% |
| Q1 2023 | $241,950 | -73.8% | 12,856 | -77.9% | 0.01% | -76.2% |
| Q4 2022 | $925,095 | -2.7% | 58,109 | 0.0% | 0.02% | -12.5% |
| Q3 2022 | $951,000 | +101.5% | 58,109 | +104.4% | 0.02% | +84.6% |
| Q3 2021 | $472,000 | -45.7% | 28,434 | -20.2% | 0.01% | -53.6% |
| Q2 2021 | $869,000 | +93.5% | 35,627 | +104.7% | 0.03% | +64.7% |
| Q1 2021 | $449,000 | +45.3% | 17,402 | +201.0% | 0.02% | +54.5% |
| Q4 2020 | $309,000 | +12.4% | 5,781 | -13.4% | 0.01% | -35.3% |
| Q3 2020 | $275,000 | -11.0% | 6,672 | -55.2% | 0.02% | -45.2% |
| Q3 2018 | $309,000 | – | 14,893 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Finepoint Capital LP | 556,553 | $11,598,565 | 5.78% |
| Baker Brothers Advisors | 42,864,612 | $893,298,514 | 5.15% |
| RTW INVESTMENTS, LP | 11,576,537 | $241,255,031 | 5.09% |
| Palo Alto Investors LP | 2,405,793 | $50,136,726 | 4.74% |
| Birchview Capital, LP | 240,400 | $5,009,936 | 4.26% |
| EcoR1 Capital, LLC | 5,991,479 | $124,862,422 | 4.21% |
| EMERALD ADVISERS, LLC | 1,681,052 | $35,033,124 | 1.70% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1,303,988 | $27,175,110 | 1.64% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 179,702 | $3,739,599 | 1.26% |
| SECTOR GAMMA AS | 179,785 | $3,746,719 | 0.96% |